Dae Hwa Pharm Co (XKRX:067080) Long-Term Debt : ₩8,750 Mil (As of Mar. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Dae Hwa Pharm Co Long-Term Debt?

Dae Hwa Pharm Co's Long-Term Debt for the quarter that ended in Mar. 2024 was ₩8,750 Mil.

Dae Hwa Pharm Co's quarterly Long-Term Debt declined from Sep. 2023 (₩8,250 Mil) to Dec. 2023 (₩7,500 Mil) but then increased from Dec. 2023 (₩7,500 Mil) to Mar. 2024 (₩8,750 Mil).

Dae Hwa Pharm Co's annual Long-Term Debt increased from Dec. 2021 (₩10,796 Mil) to Dec. 2022 (₩27,307 Mil) but then declined from Dec. 2022 (₩27,307 Mil) to Dec. 2023 (₩7,500 Mil).

Dae Hwa Pharm Co Long-Term Debt Historical Data

The historical data trend for Dae Hwa Pharm Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dae Hwa Pharm Co Long-Term Debt Chart

Dae Hwa Pharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

6,000.00

5,249.37

10,796.49

27,307.47

7,499.63

Dae Hwa Pharm Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															27,389.76	28,017.14	8,249.59	7,499.63	8,749.67

Dae Hwa Pharm Co (XKRX:067080) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Dae Hwa Pharm Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Dae Hwa Pharm Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Dae Hwa Pharm Co (XKRX:067080) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dae Hwa Pharm Co Ltd (XKRX:067080) » Definitions » Long-Term Debt

Traded in Other Exchanges

N/A

Address

495 Hanu-ro, Hoengseong-eup, Hoengseong-gun, Seoul, Gangwon-do, KOR, 225-804

Website

http://www.dhpharm.co.kr

Dae Hwa Pharm Co Ltd is a specialized pharmaceutical company. It is mainly involved in manufacturing and distribution of pharmaceutical products. The company controls approximately 70% of the domestic transdermal drug delivery system market. The company offers analgesics and anti-inflammatory drugs, antihistamines, skeletal muscle relaxants, and cardiovascular drugs. Its products are exported to Asia, South America, Africa, and the Middle East.

Dae Hwa Pharm Co (XKRX:067080) Headlines

No Headlines